Xenetic Biosciences Investor Relations Material

Xenetic Biosciences, Inc. is a biotechnology company focused on developing immune-oncology therapies and drug delivery technologies. The company specializes in advancing novel treatments for cancer, leveraging its proprietary DNase-based platform designed to improve the effectiveness of chemotherapy and immunotherapy. The company is headquartered in Framingham, Massachusetts, and its shares are listed on the NASDAQ.